Your browser doesn't support javascript.
loading
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
Andersen, Jesper A S; Spatzek, Anders D; Vilstrup, Mie H; Grupe, Peter; Hess, Søren; Holdgaard, Paw C; Bastholt, Lars; Gerke, Oke; Hildebrandt, Malene G.
Afiliação
  • Andersen JAS; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
  • Spatzek AD; University of Southern Denmark, Odense, Denmark.
  • Vilstrup MH; Open Patient Data Explorative Network, OPEN, Odense University Hospital, Odense, Denmark.
  • Grupe P; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
  • Hess S; University of Southern Denmark, Odense, Denmark.
  • Holdgaard PC; Open Patient Data Explorative Network, OPEN, Odense University Hospital, Odense, Denmark.
  • Bastholt L; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
  • Gerke O; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
  • Hildebrandt MG; Department of Clinical Research, Research Unit of Clinical Physiology and Nuclear Medicine, University of Southern Denmark, Odense, Denmark.
Eur J Nucl Med Mol Imaging ; 49(7): 2342-2351, 2022 06.
Article em En | MEDLINE | ID: mdl-35129651

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiglucose F18 / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article